Hantz Financial Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $307K | Sell |
1,191
-41,285
| -97% | -$10.6M | 0.01% | 568 |
|
2025
Q1 | $9.51M | Sell |
42,476
-1,658
| -4% | -$371K | 0.17% | 121 |
|
2024
Q4 | $10.1M | Sell |
44,134
-1,134
| -3% | -$259K | 0.18% | 125 |
|
2024
Q3 | $11.1M | Sell |
45,268
-1,341
| -3% | -$327K | 0.2% | 112 |
|
2024
Q2 | $8.92M | Sell |
46,609
-999
| -2% | -$191K | 0.17% | 148 |
|
2024
Q1 | $9.43M | Sell |
47,608
-2,340
| -5% | -$463K | 0.18% | 143 |
|
2023
Q4 | $8.59M | Buy |
49,948
+1,352
| +3% | +$233K | 0.19% | 156 |
|
2023
Q3 | $7.19M | Sell |
48,596
-2,730
| -5% | -$404K | 0.18% | 163 |
|
2023
Q2 | $11.2M | Buy |
51,326
+188
| +0.4% | +$41.1K | 0.28% | 106 |
|
2023
Q1 | $11.2M | Buy |
51,138
+861
| +2% | +$189K | 0.31% | 90 |
|
2022
Q4 | $10.5M | Buy |
50,277
+902
| +2% | +$188K | 0.32% | 95 |
|
2022
Q3 | $10.8M | Buy |
49,375
+216
| +0.4% | +$47.2K | 0.37% | 76 |
|
2022
Q2 | $10.3M | Buy |
49,159
+596
| +1% | +$125K | 0.35% | 84 |
|
2022
Q1 | $11.8M | Buy |
48,563
+2,810
| +6% | +$681K | 0.35% | 85 |
|
2021
Q4 | $11.9M | Buy |
45,753
+2,658
| +6% | +$692K | 0.34% | 85 |
|
2021
Q3 | $11.4M | Buy |
43,095
+4,900
| +13% | +$1.29M | 0.37% | 78 |
|
2021
Q2 | $9.42M | Buy |
38,195
+1,316
| +4% | +$324K | 0.35% | 81 |
|
2021
Q1 | $7.16M | Buy |
36,879
+1,298
| +4% | +$252K | 0.3% | 98 |
|
2020
Q4 | $7.56M | Buy |
35,581
+558
| +2% | +$119K | 0.34% | 79 |
|
2020
Q3 | $6M | Buy |
35,023
+642
| +2% | +$110K | 0.31% | 88 |
|
2020
Q2 | $6.6M | Sell |
34,381
-7,029
| -17% | -$1.35M | 0.37% | 72 |
|
2020
Q1 | $6.1M | Buy |
+41,410
| New | +$6.1M | 0.42% | 60 |
|